the aid library

LIST OPTIONS

Filter

9664

Sort by:

Direction:

Download (146)

View PDF (210)

Local suffering and the global discourse of mental health and human rights: An ethnographic study of responses to mental illness in rural Ghana

Ursula M Read, Edward Adiibokah and Solomon Nyame Globalization and Health (2009) CC

The Global Movement for Mental Health has brought renewed attention to the neglect of people with mental illness within health policy worldwide. The maltreatment of the mentally ill in many low-income countries is widely reported within psychiatric hospitals, informal healing centres, and family hom... more

Download (666)

View PDF (563)

SADC Regional Advocacy Strategy on HIV & Aids, Tuberculosis and Sexually Transmitted Infections

Communicable Diseases Project Directorate for Social and Human Development and Special Programmes, SADC Secretariat, Gaborone, Botswana (2015) C1

This regional advocacy strategy on HIV and AIDS, tuberculosis (TB) and sexually transmitted infetions (STIs) is intended for use by Southern African Development Community (SADC) Member States at a national level. This is an overall advocacy strategy highlighting the most important issues relating to... more

Download (240)

View PDF (358)

The 2019 Global Multidimensional Poverty Index (MPI)

United Nations Development Programme (UNDP) and the Oxford Poverty and Human Development Initiative (OPHI) (2019) C1

This year’s MPI results show that more than two-thirds of the multidimensionally poor—886 millionpeople—live in middle-income countries. A further 440 million live in low-income countries. In both groups, data show, simple national averagescan hide enormous inequality inpatterns of povertywith... more

Download (1125)

View PDF (1675)

Counterfeit Drugs - Guidelines for the development of measures to combat counterfeit medicines

World Health Organization (1999) CC

These guidelines are aimed to provide guidance to Member States in developing their own national measures to combat counterfeiting of medicines. The guidelines include: an overview of the problems and factors concerning the counterfeiting of medicines; important steps to be followed in developing na... more

Download (252)

View PDF (644)

Strategies for skills acquisition and work for people with disabilities

Thabo Mbeki Development Trust for Disabled People, Disabled People South Africa, and Human Sciences Research Council International Labour Organization (2007) C2

A report submitted to the International Labour Organization, Geneva

Download (229)

View PDF (265)

Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States

Development of Health and Human Services USA; AIDSinfo Development of Health and Human Services USA; AIDSinfo (2020) C2

Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission— A Working Group of the Office of AIDS Research Advisory Council (OARAC) Accessed: 12.02.2020

Download (178)

View PDF (179)

Situational Analysis of Antimicrobial Use and Resistance in Humans and Animals in Zimbabwe

The Center for Disease Dynamics, Economics & Policy CDDEP (2017) C2

This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ... more

Download (63)

View PDF (602)

Vatican COVID-19 Commission

The Pope Francis; Dicastery for Promoting Integral Human Development (DPIHD) (2021) C1

On 20 March 2020, Pope Francis asked the Dicastery for Promoting Integral Human Development (DPIHD) to create a Commission, in collaboration with other Dicasteries of the Roman Curia and other organizations, to express the Church’s solicitude and care for the whole human family facing the COVID-19... more

Download (133)

View PDF (164)

Global Multidimensional Poverty Index 2021 - Unmasking disparities by ethnicity, caste and gender

OPHI (Oxford Poverty and Human Development initiative) (2021) C1

Download (136)

View PDF (173)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Download (154)

View PDF (189)

Climate–Poverty Connections: Opportunities for synergistic solutions at the intersection of planetary and human well-being

Project Drawdown (2022) CC

Project Drawdown (2022) provides evidence of how climate solutions can also be win-win opportunities for meeting development and human well-being needs while boosting prosperity for rural communities in sub-Saharan Africa and South Asia. The report summarizes the co-benefits of five groups of a subs... more

Download (121)

View PDF (188)

Climate–Poverty Connections: Opportunities for synergistic solutions at the intersection of planetary and human well-being. Fact Sheet

Project Drawdown (2022) CC

Download (88)

View PDF (483)

Global Health at the Human-Animal-Ecosystem Interface

University of Geneva, Institute Pasteur, University of Montreal and Centre Virchow-VillerméUniversity Paris Descartes (2020) CC

Over the next 8 weeks, you will explore and learn about some of the major and current Global Health Challenges at the Human-Animal-Ecosystem Interface: zoonotic emerging infections (e.g. Ebola, Nipah, MERS, Avian Influenza), antimicrobial resistance, neglected tropical diseases (e.g. rabies, leishma... more

Download (67)

View PDF (587)

Treatment options for second-stage gambiense human African trypanosomiasis

Eperon, G.; Balasegaram, M.; Potet, J.; Mowbray, C.; Valverde, O.; ois Chappui, F. Informa Healthcare (2014) CC

Treatment of second-stage gambiense human African trypanosomiasis relied on toxicarsenic-based derivatives for over 50 years. The availability and subsequent use of eflornithine,initially in monotherapy and more recently in combination with nifurtimox (NECT), has drasticallyimproved the pro... more

Download (86)

View PDF (602)

New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story

Dickie, E.A.; Giordani, F.; Gould, M.K.; Mäser, P.; Burri, C.; Mottram, J.C.; Rao, S.P.S.; Barrett, M.P. MDPI Tropical Medicine and Infectious Disease (2020) CC2

The twentieth century ended with human African trypanosomiasis (HAT) epidemics raging across many parts of Africa. Resistance to existing drugs was emerging, and many programs aiming to contain the disease had ground to a halt, given previous success against HAT and the competing priorities associat... more

Download (85)

View PDF (340)

iagnostic Gaps and Recommendations for Human African Trypanosomiasis: Assessment of User Needs, Use Cases, and the Diagnostic Landscape

PATH (2016) C2

In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions... more

Download (98)

View PDF (426)

Diagnostic Gaps and Recommendations for Human African Trypanosomiasis: Assessment of User Needs, Use Cases, and the Diagnostic Landscape

Program for Appropriate Technology in Health PATH (2016) C2

This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review, product development landscape, and stakeholder interviews was compiled to: - Identify use cases and understand current diagnosti... more

Download (90)

View PDF (391)

Report of the first WHO stakeholders meeting on gambiense human African trypanosomiasis elimination

World Health Organization WHO (2014) C_WHO

The objectives of the meeting were: 1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT. 2. To share achievements, challenges and views on the elimination goal among countries and implementing partners. 3. To assess t... more

Download (91)

View PDF (411)

Report of the first WHO stakeholders meeting on rhodesiense human African trypanosomiasis Geneva, 20–22 October 2014

World Health Organization WHO (2014) C_WHO

The objectives of the meeting were: 1. To update the current status of the disease transmission, country capacities and plans for tackling the disease. 2. To understand the epidemiology including disease distribution and risk, the models for estimating under-detection, the geographical variati... more

Download (62)

View PDF (465)

Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development

Rezza G., Weaver S.C. PLOS Neglected Tropical Diseases (2019) C2

Chikungunya fever (CHIKF) is an emerging infectious disease caused by an alphavirus transmitted by Aedes spp. mosquitoes. Because mosquito control programs are not highly efficient for outbreak containment, vaccines are essential to reduce the burden of disease. Although no licensed vaccine against ... more